As India Lifts its Vaccine Export Ban – will 600 Million India-made Doses of J&J Vaccine be Shipped to Rich Western Countries?

In the coming months, 600 million doses of the Johnson & Johnson vaccines, manufactured in India, may be exported to Europe or the United States, at a time when India grapples with vaccinating its own citizens.

 

Link to the source article >> https://healthpolicy-watch.org/will-600-million-india-made-doses-of-jj-vaccine-be-exported-to-rich-western-countries/

In the coming months, 600 million doses of single-shot Johnson & Johnson vaccines, manufactured in Hyderabad, are likely to be exported to Europe or the United States, at a time when India grapples with vaccinating its own citizens. Civil-society organisations are concerned that millions of doses of the COVID-19 vaccine may end up in the developed world, in regions with already high vaccination rates.

India recorded around 30,000 to 40,000 new COVID cases on most days in September. Only 14 percent of the population is fully inoculated against the virus. Prime Minister Narendra Modi’s government promised to fully vaccinate the nation’s adult population by the end of 2021, a target impossible to reach if India, under pressure from developed nations, exports most of the doses. Concerns regarding the destination of these vaccine doses are especially relevant ahead of the Quadrilateral Security Dialogue, or the QUAD—a summit of the leaders of the United States, India, Japan and Australia that is to be held in late September. Modi will be headed to Washington for the meeting, where vaccines are likely to be discussed.

Return to the list of articles